These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 13960102)

  • 21. Studies on lysergic acid diethylamide and related compounds. Part 8. Structural identification of new metabolites of lysergic acid diethylamide obtained by microbial transformation using Streptomyces roseochromogenes.
    Ishii H; Niwaguchi T; Nakahara Y; Hayashi M
    J Chem Soc Perkin 1; 1980; 4():902-5. PubMed ID: 7190156
    [No Abstract]   [Full Text] [Related]  

  • 22. THE USE OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN PSYCHOTHERAPY.
    BAKER EF
    Can Med Assoc J; 1964 Dec; 91(23):1200-2. PubMed ID: 14226093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [LSD-25 & psychomotor epilepsy].
    BALESTRIERI A; FONTANARI D
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):504-5. PubMed ID: 13466971
    [No Abstract]   [Full Text] [Related]  

  • 24. [A review on the use of lysergic acid diethylamide in psychiatry].
    WIJSENBEEK H; LANDAU R
    Harefuah; 1960 May; 58():281-6. PubMed ID: 13844712
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 26. [D-Lysergic acid diethylamide (LSD). 2. Clinical aspects].
    GROF S; VOJTECHOVSKY M; VOTAVA Z
    Lek Veda Zahr; 1960; 11():245-51 contd. PubMed ID: 13858660
    [No Abstract]   [Full Text] [Related]  

  • 27. The metabolism of lysergic acid diethylamide.
    BOYD ES
    Arch Int Pharmacodyn Ther; 1959 Jul; 120():292-311. PubMed ID: 13803540
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy with lysergic acid diethylamide.
    LEWIS DJ; SLOANE RB
    J Clin Exp Psychopathol; 1958; 19(1):19-31. PubMed ID: 13525450
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD).
    KOELLE GB
    N Engl J Med; 1958 Jan; 258(1):25-32. PubMed ID: 13493730
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lysergic acid diethylamide and psychiatry. General introduction].
    DURAND VJ
    Ann Med Psychol (Paris); 1960 Mar; 118(1)():401-526. PubMed ID: 13818790
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lysergic acid diethylamide. 3. Practical and theoretical problems in administration of LSD to human subjects].
    GROF S; VOJTECHOVSKY M; VOTAVA Z
    Lek Veda Zahr; 1960 Dec; 12():276-84. PubMed ID: 13858661
    [No Abstract]   [Full Text] [Related]  

  • 32. Complex partial and pseudoseizure disorders.
    Remick RA; Wada JA
    Am J Psychiatry; 1979 Mar; 136(3):320-3. PubMed ID: 420329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fluorometric determination of lysergic acid diethylamide and ergonovine.
    BOYD ES
    Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):43-51. PubMed ID: 13545885
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of lysergic acid diethylamide on digit span.
    SILVERSTEIN AB; KLEE GD
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1960; 21():11-4. PubMed ID: 14446780
    [No Abstract]   [Full Text] [Related]  

  • 35. Cholinesterase, dlysergic acid diethylamide, and 2-bromolysergic acid diethylamide.
    BERTINO JR; KLEE GD; WEINTRAUB W
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1959; 20():218-22. PubMed ID: 13799991
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of lysergic acid diethylamide on the modification of a learned jumping response.
    PAWLOWSKI AA
    J Neuropsychiatr; 1962; 4():81-6. PubMed ID: 13942132
    [No Abstract]   [Full Text] [Related]  

  • 37. [Psychomotor effects in acute and chronic poisoning with amine derivatives of lysergic acid diethylamide].
    TONINI G; BABBINI M; MISSERE G
    Boll Soc Ital Biol Sper; 1959 Sep; 35():1117-9. PubMed ID: 13838806
    [No Abstract]   [Full Text] [Related]  

  • 38. [Psychic effects of lysergic acid diethylamide].
    HAASE HJ
    Fortschr Neurol Psychiatr Grenzgeb; 1957 Oct; 25(10):546-70. PubMed ID: 13474070
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of D-lysergic acid diethylamide (LSD-25) on learning and retention.
    ARONSON H; WATERMANN CE; KLEE GD
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1962; 23():17-23. PubMed ID: 13862516
    [No Abstract]   [Full Text] [Related]  

  • 40. THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO LYSERGIC ACID TARTRATE (BOL-148) ON SPECIFIC CHOLINESTERASE AND MONOAMINE OXIDASE OF RAT LIVER AS POSSIBLE FACTORS IN THE MECHANISM OF HALLUCINATION. A HISTOCHEMICAL STUDY.
    NANDY K; SHANTHAVEERAPPA TR; BOURNE GH
    Acta Histochem; 1964 Apr; 17():259-67. PubMed ID: 14190338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.